This acquisition will add foliglurax in clinical phase II to its pipeline of innovative treatments for patients suffering from Parkinson's disease
Attachment

Lundbeck announced on 16 March 2018 that it will acquire Prexton Therapeutics for up to EUR 905 million.

Full press release

Find an actor

BioAlps World Visibitlity Package 201918.03.2019

A yearly international programme for our affiliated companies to increase their visibility.

"Bristol-Myers Squibb to Acquire Celgene for About Billion"

"The combined company will have nine products with more than billion in annual sales"
Print this page Download this page (PDF) Recommend this page to a friend

Contact us

BioAlps Association
Ch. du Pré-Fleuri 3
CH - 1228 Plan-les Ouates
+41 22 304 40 40
+41 22 304 40 70

Subscribe to our newsletter

Find us on LinkedIn